| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/26/2003 | CA2446292A1 Nucleic acid-associated proteins |
| 06/26/2003 | CA2412627A1 Genes and proteins involved in the biosynthesis of lipopeptides |
| 06/25/2003 | EP1321533A2 Nucleic acid, probe comprising the nucleic acid and screening method using the probe |
| 06/25/2003 | EP1321531A2 Multiplex pcr primer set for human hnf-1alpha gene amplification |
| 06/25/2003 | EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 06/25/2003 | EP1321525A2 Fruit ripening-related genes |
| 06/25/2003 | EP1321524A1 Method of increasing the transgene-coded biomolecule content in organisms |
| 06/25/2003 | EP1321523A2 Selection marker gene free recombinant strains; a method for obtaining them and the use of these strains |
| 06/25/2003 | EP1321521A1 Ribozymes directed against flt-1 |
| 06/25/2003 | EP1321519A1 Polypeptide having L-asparaginase activity |
| 06/25/2003 | EP1321518A1 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof |
| 06/25/2003 | EP1321476A2 Binding protein |
| 06/25/2003 | EP1321475A1 Gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogensis and use thereof |
| 06/25/2003 | EP1321474A1 A method for inducing apoptosis |
| 06/25/2003 | EP1321176A1 Method and device for isolating and purifying a polynucleotide of interest on a manufacturing scale |
| 06/25/2003 | EP1321034A1 Disruption of the phosphodieterase 10 gene |
| 06/25/2003 | EP1321033A1 Transgenic expression of glycogen synthase kinase 3 in muscle |
| 06/25/2003 | EP1320827A1 Determination of optimal local sequence alignment similarity score |
| 06/25/2003 | EP1320793A2 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping |
| 06/25/2003 | EP1320750A2 Methods for identifying agents causing a lethal phenotype |
| 06/25/2003 | EP1320632A2 Method for determining the age of individuals |
| 06/25/2003 | EP1320631A2 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 06/25/2003 | EP1320630A1 Degenerate oligonucleotide gene shuffling |
| 06/25/2003 | EP1320629A2 Cellular arrays for the identification of altered gene expression |
| 06/25/2003 | EP1320628A2 Process for allele discrimation utilizing primer extension |
| 06/25/2003 | EP1320627A2 Mitochondrial dosimeter |
| 06/25/2003 | EP1320626A2 Fermentation process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 06/25/2003 | EP1320624A2 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
| 06/25/2003 | EP1320623A1 Promoter sequences |
| 06/25/2003 | EP1320622A2 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 06/25/2003 | EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 06/25/2003 | EP1320620A2 Production of viral vectors |
| 06/25/2003 | EP1320619A1 Chimeric vectors and their use for heterologous genes transfer |
| 06/25/2003 | EP1320618A2 Nucleotide sequences mediating male fertility and method of using same |
| 06/25/2003 | EP1320617A1 Genetic engineering of syringyl-enriched lignin in plants |
| 06/25/2003 | EP1320615A1 Aminopeptidase |
| 06/25/2003 | EP1320614A2 Novel proteases |
| 06/25/2003 | EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/25/2003 | EP1320611A2 Heterologous production of polyketides |
| 06/25/2003 | EP1320610A1 Nucleotide sequences which code for the cobw gene |
| 06/25/2003 | EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/25/2003 | EP1320608A1 Nucleotide sequences which code for the msik gene |
| 06/25/2003 | EP1320607A2 HYPERSENSITIVE RESPONSE ELICITOR FROM i XANTHOMONAS CAMPESTRIS /i |
| 06/25/2003 | EP1320606A2 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer) |
| 06/25/2003 | EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof |
| 06/25/2003 | EP1320604A2 Cripto mutant and uses thereof |
| 06/25/2003 | EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 06/25/2003 | EP1320602A2 Spas-1 cancer antigen |
| 06/25/2003 | EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 06/25/2003 | EP1320600A1 Transporters and ion channels |
| 06/25/2003 | EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 06/25/2003 | EP1320598A2 Polypeptides and corresponding molecules for disease detection and treatment |
| 06/25/2003 | EP1320597A2 Induction of exon skipping in eukaryotic cells |
| 06/25/2003 | EP1320596A1 Method of performing reverse transcription reaction using reverse transcriptase encoded by non-ltr retrotransposable element |
| 06/25/2003 | EP1320595A2 Production process of surfactin |
| 06/25/2003 | EP1320594A2 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics |
| 06/25/2003 | EP1320592A2 "15985", a human serine/threonine protein kinase family member and uses thereof |
| 06/25/2003 | EP1320591A2 Atcr-1, a human acyltransferase and uses thereof |
| 06/25/2003 | EP1320590A2 47885, a novel human ubiquitin-activating enzyme and uses therefor |
| 06/25/2003 | EP1320585A2 Oxidoreductases |
| 06/25/2003 | EP1320584A2 Transferases |
| 06/25/2003 | EP1320583A2 Enhanced replication of hcv rna |
| 06/25/2003 | EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 06/25/2003 | EP1320579A2 High growth methanotrophic bacterial strain methylomonas 16a |
| 06/25/2003 | EP1320550A2 G-protein coupled receptors |
| 06/25/2003 | EP1320549A2 Pumpcn compositions and uses thereof |
| 06/25/2003 | EP1320548A2 Transporters and ion channels |
| 06/25/2003 | EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/25/2003 | EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 06/25/2003 | EP1320542A2 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 06/25/2003 | EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 06/25/2003 | EP1320377A1 Hla binding peptides and their uses |
| 06/25/2003 | EP1320292A2 Method of cloning porcine animals |
| 06/25/2003 | EP1294221A4 Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection |
| 06/25/2003 | EP1123160B1 Device for conducting biochemical and microbiological reactions |
| 06/25/2003 | EP1117693A4 Intein mediated peptide ligation |
| 06/25/2003 | EP1088105A4 Detection of non-viral organisms with srp rna |
| 06/25/2003 | EP1019428B1 Inverted chimeric and hybrid oligonucleotides |
| 06/25/2003 | EP0941365B1 Novel probes for the detection of mycobacteria |
| 06/25/2003 | EP0906434B1 Mch4 AND Mch5, APOPTOTIC PROTEASE, NUCLEIC ACIDS ENCODING AND METHODS OF USE |
| 06/25/2003 | EP0877807B1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 06/25/2003 | EP0854924B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 06/25/2003 | EP0828852B1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types |
| 06/25/2003 | EP0753073B1 Heat-inducible n-degron module |
| 06/25/2003 | EP0744958B1 Polyclonal antibody libraries |
| 06/25/2003 | EP0679182B1 Delivery of gene products via mesangial cells |
| 06/25/2003 | EP0678121B1 Methods and reagents for inhibiting furin endoprotease |
| 06/25/2003 | EP0675951B1 An enzyme with endoglucanase activity |
| 06/25/2003 | EP0668879B1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 06/25/2003 | EP0650524B1 Detection of the cytolysin gene with oligonucleotides |
| 06/25/2003 | EP0633938B1 Methods for producing substantially pure eg iii cellulase using alcohol |
| 06/25/2003 | EP0620849B1 Transgenic animal models for alzheimer's disease |
| 06/25/2003 | EP0618969B1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 06/25/2003 | EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g |
| 06/25/2003 | EP0563189B1 Genetically engineered modification of potato to form amylopectin-type starch |
| 06/25/2003 | EP0480024B1 Dna encoding plant thioesterases |
| 06/25/2003 | CN1426482A Diagnostics and therapeutics for glaucoma |
| 06/25/2003 | CN1426481A Microarray-based analysis of polycleotide sequence variations |
| 06/25/2003 | CN1426480A Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target |
| 06/25/2003 | CN1426478A Prion-free transgenic ungulates |